Background: Nutritional supplements have received attention both from food manufacturers, as a means of marketing the added value to health; and from consumers, in terms of awareness, education, and improved health. To assist this process, it is important to have specific knowledge and understanding of the claims made on labels of nutritional supplement products used for general, and more specifically, for sports consumers. The industry is not regulated, and therefore the claims that are made may not always be accurate.
Introduction
Nutritional supplements have received attention, both from manufacturers as a means of marketing the added value to health; and from consumers, in terms of awareness, education, and improved health. A supplement is a product taken orally that contains a "dietary ingredient" intended to supplement the diet. The "dietary ingredients" in these products may include vitamins, minerals, herbs, or other botanicals, amino acids, and substances, such as enzymes, organ tissues, glandulars, and metabolites. 1 The regulatory framework of nutritional supplements should be compatible with public health and safety, protect the consumer, promote fair trade, and encourage innovation. [2] [3] [4] Consumer structures need to play a greater role in the development of a sound nutritional supplement management system, to ensure that appropriate legislation and regulation are developed and enforced on a sustainable basis, in line with the Consumer Protection Act (CPA) 68 of 2008. 5 Section 29 of the CPA specifically states that a producer, importer, distributor, retailer or service provider, must not market any goods or services in a manner that is reasonably likely to imply a false or misleading representation, and that is misleading, fraudulent or deceptive in any way. Section 41 of the CPA specifically provides, and outlines, how claims that have been made could be affected. 5 The South African Medical Control Council published a August 2011 guideline for comment, with regard to the quality, safety, and efficacy of complementary medicine. This guideline and its implementation could have relevance, and apply to nutritional supplements when it becomes law. If the specific scheduled complementary medicine or active ingredients that have an established identity and tradition of use, determined or known, are not declared on the label, or when claims are made, and are not clearly substantiated by peer-review scientific processes, a legal challenge could result.
2012;25(1) S Afr J Clin Nutr products are categorised as nutritional supplements, and as such, do not need to undergo rigorous testing to confirm safety and efficacy. In South Africa, a 2004 survey detected that 12 (40%) out of 30 overthe-counter nutritional supplements contained banned substances, such as ephedrine. 7, 8 To assist this process, it is important to have specific knowledge and understanding of the claims made on the labels of nutritional supplements products used for general, and more specifically, sports consumers. In particular, labelling information, including warnings, claims, disclaimers, as well as proposed mechanisms of action, needs to be documented.
All this information is needed for practical intervention, policy development, and possible appropriate legislation and regulation. Such information may also further provide and facilitate the design of guidelines on how nutritional supplement products may be marketed in future, and ensure that the consumer makes informed choices. In accordance with these points, the aim of this study was to select a group of nutritional products, either imported, or manufactured in South Africa, and quantify the labelling and claims information on the labels.
Method
Nutritional supplement products were purchased at Century City Dischem Pharmacy in Canal Walk, Cape Town, Western Cape, South Africa. They consisted of internationally imported, and locally manufactured or assembled products, based on the list of top sellers as determined by sales at the Dischem store purchased, and within the available budget for the project. Labelling information and claims that appeared on the containers were assessed according to specific predetermined categories. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] The categories included claims made on containers, general information, disclaimers, warnings, quality assurance, scientific pledge, and consumer or public relations categories. 
Results
Forty products were selected for analysis, of which 21(53%) were locally assembled or manufactured products, and 19 (48%), international imported products. The formulations consisted of powders (40%), capsules (33%), tablets (20%), and liquid in capsules (8%). Only 10% of the product labels cited a literature reference, and of these, 75% cited studies carried out in humans. Thirty per cent of the products contained a statement on the labels indicating that the product was "contaminant -free".
Ninety-five per cent of the nutritional supplements referred to a website on their labels. All the products provided information with the directions for use. Ninety-five per cent had a "best before" date and expiry date for the consumption of the specific product and 95% had batch numbers on the nutritional supplement labels. The mean number of ingredients/compounds described on each label was 28, with a range of 1 to 88. There was an average of five colours (ranging from three to nine) on each label.
Ninety-five per cent of products carried a warning statement on the label. Often, these statements were printed in a small font size, and were not immediately noticeable. The number of warnings ranged from none to 14 per product, with a mean of five. The warning categories on nutritional supplement labels assessed in this study are shown in Table I . Table I : The 17 warning categories assessed on the product labels (n = 40)
Warning descriptions
Total %
Keep product out of reach of children 27 68
Importance of adherence to storage details 23 57
Use during pregnancy and lactation 17 43
Exceeding recommended dose 17 43
Importance of consultation with healthcare professionals 17 43
Age categories for consumption 12 30 Lower dose when experiencing adverse events 10 25
Nutritional supplements should not replace dietary requirements 10 25 Potentiate and suppress the effect of drugs 10 25 Certain medical conditions and the use of supplements 10 25
Importance of staying hydrated 8 20 Time restriction consideration when consuming product 4 10
Maximum dose "dangers" 4 10
Presence of banned substances in the supplements 2 5
Presence of food items associated with allergies or intolerance 2 5
Product is gender specific 1 2
Exclusion of use, and not a cure for disease 1 2 Eighty-five per cent of the nutritional supplement products contained a disclaimer on the label. A disclaimer was defined as any statement intended to specify or delimit the scope of rights and obligations that may be exercised and enforced by parties in a legally recognised relationship. Table II represents the disclaimers that were observed on the product labels in this study. The product is free of stimulants, colourants, flavourants or preservatives
40
The product, or claim made by the product, has not been evaluated by the US Food and Drug Administration 12 30
The product should not replace medication 7 18 24 Original Research: Information on nutritional supplement labels: time for legislation?
2012;25(1) S Afr J Clin Nutr Ninety-eight per cent of the nutritional supplement products labels included a claim on the label. The different categories and numbers of supplements within each category are shown in Table III. All the nutritional supplement products labels (100%) contained some scientific indication or pledge, and 60% of the nutritional supplements included scientific or research claims on the labels. These claims were not necessarily peer-reviewed.
Forty per cent of the supplements had pledges or an indication of commitment to the nutritional supplements assessed, and 35% made a pronouncement on a specific technology or specific patent used in the manufacture of the nutritional supplement. Thirty-three per cent of the nutritional supplement products contained advertising on the label, and eight per cent of the nutritional supplement products provided a link to social networks, e.g. facebook, twitter. Use of pseudo-scientific terms (Table IV) 15 38
Will increase physical performance 15 37
Provides increased strength 13 33
Improves recovery 13 32
Supports general metabolism 12 30 Supports fat metabolism 7 18 Can have an effect on mood changes 7 18
Outrageous claims (Table IV)  7  17 Supports cognitive function 6 15 Serves as a weight loss or management product 5 12 Removal of metabolic by-products 5 12
Serves as an appetite suppressant 4 10
Supports glucose metabolism 4 10
Supports testosterone metabolism 4 10 Gives support to the immune system 4 10
Provides antioxidant properties 4 10
Research supports evidence 4 10
Serves as a meal replacement 2 5
Relieves stress 2 5
Could alter libido 2 5 2012;25(1) S Afr J Clin Nutr
Discussion
This study has provided diverse examples of the labelling of nutritional supplements. The 40 nutritional supplement products that were assessed as part of this study yielded the following information.
Seventy per cent of the nutritional supplement product labels provided no indication or evidence that the product was "contaminant-free". This can be interpreted as either an expression of confidence that the quality of the products are good, and therefore there is no concern about possible contamination, or that the manufacturer is unaware of possible contaminants in the products. This suggests that it is important to carry out screen testing of products to verify whether or not nutritional supplements contain contaminants, with specific regard to steroids and stimulants. Even if "contaminant-free" information is included on labels, this does not guarantee that the products are free of contaminants, especially as these products are produced in an environment that is not governed by manufacturing regulations. Although the label may state that the product is stimulant-free, no legislation exists to monitor the accuracy of this statement. Furthermore, the word "stimulant" may also be used in a generic way. Therefore, certain stimulants may be absent, while others may be present, either unintentionally, or deliberately, due to the manufacturing process. 19, 20 Of the nutritional supplements assessed, 95% carried warning statements. On average, there were five warnings per supplement. One supplement contained 14 warnings. The two most frequently used warning statements on the assessed product labels were: "Keep this product out of the reach of children" (68%), and "It is important to adhere to the storage details" (57%). Both these warnings alert the consumer to potential harm. However, often the children alert did not give a specific age. Less common warning statements, but possibly of greater significance were: "Exclusion of use, and not a cure for disease states" (2%), and the "Presence of banned substances in the supplements (5%)". With regard to the former, products may contain contaminants that could directly, or indirectly, contribute to, or exacerbate, specific disease states. The latter might affect professional athletes, who could test positive for a banned substance after ingesting a supplement. The potential implication for the general consumer is the impact on long-term health consequences, due to harmful, continuous, intermittent-use effects, or the accumulative effects over time.
In Australia and New Zealand, new labelling initiatives pertaining to food standards require mandatory nutrition information panels. Substances that may cause adverse reactions have to be highlighted on the label. In context, this approach to labelling could also have similar application to nutritional supplement products. 21 Incorrect storage of the nutritional supplement product, e.g. the wrong temperature, has the potential to convert "active" chemical compounds to other active or inactive chemical moieties, or completely harmful unknown compounds. 19 The consequence of consumption of such nutritional supplement products could be adverse events. The same logic applies to the consumption of gender-specific products, if not labelled adequately for a specific sex. Unintended consequences that impact on the physiological hormonal balance of a specific sex may occur if compounds that are present in the supplements are not declared on the label. [22] [23] [24] Consumers who fail to comply with the directions for use, could also predispose themselves to the long-term effects of elevated accumulative doses. This could cause adverse effects due to abnormal physiological or normal cell disruptive activity.
Industry-sector, standardised batch number coding on nutritional supplement products, with a data trail from the manufacturing process to the consumer environment, would be useful. Such an approach would facilitate good manufacturing practice (GMP) processes, and should also identify potential contaminant entry points.
Although best-before and expiry date information is valuable, in many cases, it was not clearly visible on the label. In the context of warning statements, a recent study designed to determine nutrition knowledge, and understanding of nutritional information, concluded that only 27% of respondents looked at package information before making a decision. 25 Another study suggested that older, as opposed to younger consumers, detect information changes less readily. 22 Thus, newly-added information does not necessary reach all consumers, and this poses a potential problem for policy makers and scientists. 26 A study designed to determine the factors that draw consumers' attention to nutritional labels showed that the display size, colour scheme, and familiarity with the label, the logo and its location on the front of the pack, are key determinants. 27 The study revealed that when consumers have a sound understanding of nutrition information, and gave their attention to the label content, this impacted on nutritional supplement choice. 27 An off-label promotion study concluded that the media helps shape public perceptions, and increases support for regulatory actions. 28 "Off-label" is defined as a drug or product used for indications that are not approved by the US Food and Drug administration (FDA). This study concluded that primary concerns about label content include legal concerns, lack of safety or efficacy data, and having no ethical, or clinical content. Having this type of information on the label would ensure that policy and decision makers, healthcare professionals, patients, and the general public, are able to gather sufficient knowledge to make informed choices. 28 The findings in this study are supported by a study that suggests that nutrition education can be instrumental in encouraging, stimulating, motivating, and providing technical help for consumers. 29 Technical messages should include teaching consumers simple rules to interpret label information, and to incorporate the information into planning. 29 Other alternative preventative approaches, as well as improved label design for the purposes of providing nutritional information, should be researched and implemented, if results show these to be more effective. 30 From this study, it may be concluded that ongoing screen testing of nutritional supplement products is important. In particular, the products would need to be tested batch to batch for contaminants, including steroids and stimulants. The presence and quantity of the ingredients on the label would also need to be verified. Peerreview scientific evidence would ensure relevant engagement with 2012;25(1) S Afr J Clin Nutr social media networks, and provide education and awareness to the consumer in an informed way. This would also emphasise the importance of relevant screening of the "knowns" with regard to number of ingredients on the label information (both qualitatively and quantitatively), and "unknowns", to be determined or discovered, but not reflected on the label information.
This study highlighted concerns about claims and labelling, but the apprehension is compounded by the lack of structures of governance and policy development, that need to ensure the transition from selfregulation to enhanced regulation of the nutritional supplement sector. The importance of screen testing for contaminants and adulterants, and in particular, steroids and stimulants, is apparent.
Conclusion
The following information needs to be regulated, and enforced with regard to the labelling process to ensure that consumers can make informed choices:
• Highlighting the potential for adverse events, by providing this information on the label • Warning statements such as: "Keep this product out of reach of children", and "It is important to adhere to storage details" should be included on all labels in an appropriate way, using an acceptable font and visibility.
• Warning statements, such as: "Exclusion of use, and not a cure for disease states", and "Sportsmen should note that there are banned substances in the supplements", should be encouraged. These statements should be based on standardised laboratory screen methods.
• A nutritional supplement sector-specific system and guideline with regards to the best-before and expiry-date information, batch numbers, and GMP, that will also facilitate batch-to-batch laboratory screen testing, should be determined and established.
• An alternative label design, that would be beneficial with regard to providing relevant information to the consumer, needs to be scientifically explored and researched.
